Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FNS who wrote (5849)	1/5/1999 10:17:00 PM
From: John Metcalf	Read Replies (1) of 6136

I wonder what biotech sell-off you guys are talking about. Amex Biotech Index (^BTK) was up 1.21% today to a new annual high close, having rallied 80% since Aug 31. The Nasdaq Biotech Index was up .3%. There is considerable enthusiasm for the sector from Sangstat's approval yesterday, Immunex' continuing run, and broadly reported advances in gene therapy, to name a few hot items. IMNX was up $10 today, and was not even in the top 25 biotech percentage gainers. Where was the sell-off?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next